Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

NCT06780332 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria
PKU

Interventions

DRUG: RDD to Palynziq

Sponsor

BioMarin Pharmaceutical